These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity. Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211 [TBL] [Abstract][Full Text] [Related]
4. Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain. Herczenik E; van Haren SD; Wroblewska A; Kaijen P; van den Biggelaar M; Meijer AB; Martinez-Pomares L; ten Brinke A; Voorberg J J Allergy Clin Immunol; 2012 Feb; 129(2):501-9, 509.e1-5. PubMed ID: 21962992 [TBL] [Abstract][Full Text] [Related]
5. Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation. Zerra PE; Arthur CM; Chonat S; Maier CL; Mener A; Shin S; Allen JWL; Baldwin WH; Cox C; Verkerke H; Jajosky RP; Tormey CA; Meeks SL; Stowell SR Front Immunol; 2020; 11():905. PubMed ID: 32582142 [TBL] [Abstract][Full Text] [Related]
6. Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner. Batsuli G; Ito J; York ES; Cox C; Baldwin W; Gill S; Lollar P; Meeks SL Front Immunol; 2023; 14():1233356. PubMed ID: 37720212 [TBL] [Abstract][Full Text] [Related]
7. Accelerated antigen presentation and elicitation of humoral response in vivo by FcgammaRIIB- and FcgammaRI/III-mediated immune complex uptake. Yada A; Ebihara S; Matsumura K; Endo S; Maeda T; Nakamura A; Akiyama K; Aiba S; Takai T Cell Immunol; 2003 Sep; 225(1):21-32. PubMed ID: 14643301 [TBL] [Abstract][Full Text] [Related]
8. Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor. Georgescu MT; Moorehead PC; Liu T; Dumont J; Scott DW; Hough C; Lillicrap D Front Immunol; 2020; 11():138. PubMed ID: 32117285 [TBL] [Abstract][Full Text] [Related]
10. Long-term tolerance to factor VIII is achieved by administration of interleukin-2/interleukin-2 monoclonal antibody complexes and low dosages of factor VIII. Liu CL; Ye P; Lin J; Djukovic D; Miao CH J Thromb Haemost; 2014 Jun; 12(6):921-31. PubMed ID: 24684505 [TBL] [Abstract][Full Text] [Related]
11. A cellular viewpoint of anti-FVIII immune response in hemophilia A. André S; Meslier Y; Dimitrov JD; Repessé Y; Kaveri SV; Lacroix-Desmazes S; Dasgupta S Clin Rev Allergy Immunol; 2009 Oct; 37(2):105-13. PubMed ID: 19165635 [TBL] [Abstract][Full Text] [Related]
12. Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated. Chen Y; Luo X; Schroeder JA; Chen J; Baumgartner CK; Hu J; Shi Q J Thromb Haemost; 2017 Oct; 15(10):1994-2004. PubMed ID: 28799202 [TBL] [Abstract][Full Text] [Related]
13. Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro. Werwitzke S; Vollack N; von Hornung M; Kalippke K; Kutzschbach J; Trummer A; Ganser A; Tiede A Thromb Haemost; 2015 Nov; 114(6):1127-35. PubMed ID: 26245154 [TBL] [Abstract][Full Text] [Related]
14. Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A mice. Lai JD; Cartier D; Hartholt RB; Swystun LL; van Velzen AS; den Haan JMM; Hough C; Voorberg J; Lillicrap D J Thromb Haemost; 2018 Mar; 16(3):533-545. PubMed ID: 29285874 [TBL] [Abstract][Full Text] [Related]
15. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity. Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275 [TBL] [Abstract][Full Text] [Related]
16. The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells. Gangadharan B; Ing M; Delignat S; Peyron I; Teyssandier M; Kaveri SV; Lacroix-Desmazes S Haematologica; 2017 Feb; 102(2):271-281. PubMed ID: 27758819 [TBL] [Abstract][Full Text] [Related]